DA Banner

2010 DART Research Projects

DART Grants 2010

 

Below is a list of winners of the 2010 Millennium Grants

 

Name Institution Type of Diabetes Short Title
Prof. Jogesan Kanagasingam University of Western Australia Type 1 A Low Cost, Easy-to-Operate, Non-Invasive Diabetic Retinopathy Screening Device
Dr Sof Andrikopoulos University of Melbourne Type 2 Unravelling the mechanisms by which insulin hypersecretion is detrimental to ß-cell function and survival in Type 2 diabetes


Below is the winner of this year's Viertel winner.

Name Institution Type of Diabetes Short Title
Dr Sean McGee Deakin University Type 2 HDAC inhibition as an exercise mimetic and treatment for obesity and type 2 diabetes

Below is a list of  the winners of the 2010 DART Grants.


Name Institution Type of Diabetes Short Title
A/Prof Peter Thorn University of Queensland Type 2 Are there two mechanisms of insulin secretion?
A/Prof Lea Delbridge University of Melbourne Type 1/ Type 2 Cardiomyocyte autophagy: Is too much of a good thing bad for the diabetic heart?
Dr SueLynn Lau Garvan Institute of Medical Research Type 2 The role of vitamin D signalling in diabetes pathogenesis in the Type 1-alpha-hydroxylase knockout mouse.

Dr Stuart Mannering

 St.Vincent’s Institute of Medical Research Type 1 Towards insulin-specific peptide therapy to prevent Type 1 diabetes
A/Prof Matthew Watt Monash University Type 2 Liver secretory factors link fatty liver to inflammation and insulin resistance
Prof John Headrick Griffith University Type 1/Type 2/Complications Protecting the Diabetic Heart: Cell Signalling Changes and the Effects of Age
Dr Lars Ittner University of Sydney Complications Effects of defective insulin signaling on tau pathology in a transgenic Alzheimer disease mouse models
Prof Julie Owens University of Adelaide Type 2 Does periconceptional folic acid supplementation alter metabolic health of progeny?
A/Prof Graham Hillis The George Institute Complications An assessment of the clinical value of biomarkers in the prediction of cardiovascular complications in patients with type ii diabetes mellitus
Prof David James Garvan Institute of Medical Research Type 2 The use of traditional Chinese Medicines to identify novel small molecules and their targets for development of novel therapies for Type 2 diabetes
Dr David Nikolic-Paterson Monash University Complications A novel approach for the early detection of diabetic kidney disease.
Dr Suzanne Rogers University of Melbourne Type2 Nutrient-stimulated glucose transport regulates whole body glucose homeostasis.
Dr Jacqueline Stoeckli Garvan Institute of Medical Research Type 2 Mechanistic studies of exercise versus insulin regulation of glucose uptake in skeletal muscle.
A/Prof John Whitehead University of Queensland Type 2 Investigating whether reduced adiponectin sialylation contributes to reduced circulating adiponectin levels: a role for the hepatic asialoglycoprotein receptor ?
Prof Michael Davies Heart Research Institute Complications Role of hyperglycaemia in inducing dysfunction in arterial endothelial cells
Dr Emma Duncan University of Queensland Other Bone Regulation of Energy Metabolism: The Role of Osteocalcin in Determining Obesity and Insulin Resistance.
Dr Morton Burt Flinders University Other Acute and chronic effects of glucocorticoids on carbohydrate metabolism in elderly subjects
Dr  Briony Forbes University of Adelaide Type 2 Defining the insulin receptor phosphorylation “barcode” responsible for metabolic and mitogenic signalling
Dr Gerard Hoyne University of Notre Dame Australia Type 2 Understanding the molecular control of Type Type 2 diabetes and obesity
Dr Christina Jang University of Melbourne Type 2 Epigenetic regulation of the 11 beta hydroxysteroid dehdrogenase enzymes, 11bHSD1 and 11bHSD2 in Type 2 Diabetes
Prof Christina Mitchell Monash University Type 2 The role of SKIP in regulating glucose homeostasis in skeletal muscle
Prof Anne-Louise Ponsonby Royal Children's Hospital Type 1 Low neonatal Type 25OHD3 levels and subsequent risk of type Type 1 diabetes mellitus in childhood.
Dr Charmaine Simeonovic The John Curtin School of Medical Research Type 1 Molecular remodeling of isolated islets for optimal survival and function of islet transplants
A/Prof Tony Tiganis Monash University Type 2 Regulation of CNTF signaling by TCPTP


 

More Information


For information on the DART Grants program email dart@diabetesaustralia.com.au.